- Home
- MTNB vs TTNP Comparison
MTNB vs TTNP Comparison
Compare MTNB & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- TTNP
- Stock Information
- Founded
- MTNB 2013
- TTNP 1991
- Country
- MTNB United States
- TTNP United States
- Employees
- MTNB N/A
- TTNP N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTNB Health Care
- TTNP Health Care
- Exchange
- MTNB Nasdaq
- TTNP Nasdaq
- Market Cap
- MTNB 3.6M
- TTNP 3.4M
- IPO Year
- MTNB N/A
- TTNP 1996
- Fundamental
- Price
- MTNB $0.83
- TTNP $4.64
- Analyst Decision
- MTNB Hold
- TTNP
- Analyst Count
- MTNB 1
- TTNP 0
- Target Price
- MTNB N/A
- TTNP N/A
- AVG Volume (30 Days)
- MTNB 354.4K
- TTNP 59.1K
- Earning Date
- MTNB 05-15-2025
- TTNP 05-14-2025
- Dividend Yield
- MTNB N/A
- TTNP N/A
- EPS Growth
- MTNB N/A
- TTNP N/A
- EPS
- MTNB N/A
- TTNP N/A
- Revenue
- MTNB N/A
- TTNP N/A
- Revenue This Year
- MTNB N/A
- TTNP N/A
- Revenue Next Year
- MTNB N/A
- TTNP N/A
- P/E Ratio
- MTNB N/A
- TTNP N/A
- Revenue Growth
- MTNB N/A
- TTNP N/A
- 52 Week Low
- MTNB $0.47
- TTNP $3.03
- 52 Week High
- MTNB $9.60
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- MTNB 60.02
- TTNP 54.33
- Support Level
- MTNB $0.77
- TTNP $4.16
- Resistance Level
- MTNB $1.17
- TTNP $4.91
- Average True Range (ATR)
- MTNB 0.12
- TTNP 0.41
- MACD
- MTNB -0.00
- TTNP -0.02
- Stochastic Oscillator
- MTNB 30.72
- TTNP 50.77
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.